Creo Medical Group PLC (LON:CREO)’s stock price traded up 2% on Tuesday . The stock traded as high as GBX 178.40 ($2.35) and last traded at GBX 178 ($2.34), 76,351 shares traded hands during mid-day trading. An increase of 376% from the average session volume of 16,051 shares. The stock had previously closed at GBX 174.50 ($2.30).
The company has a debt-to-equity ratio of 2.00, a current ratio of 9.50 and a quick ratio of 9.36. The company has a market cap of $266.92 million and a PE ratio of -14.67. The business’s 50 day moving average is GBX 182.21 and its 200-day moving average is GBX 168.05.
In related news, insider David Gerard Woods bought 25,000 shares of the company’s stock in a transaction on Tuesday, December 24th. The shares were purchased at an average cost of GBX 180 ($2.37) per share, for a total transaction of £45,000 ($59,194.95).
Creo Medical Limited develops and sells instruments for surgical endoscopy in the United Kingdom. The company is developing instruments for endoscopy through a combination of bipolar radiofrequency and microwave energy in a single platform for tissue dissection, resection, ablation, and coagulation. It offers Speedboat RS2 instrument for endoscopic submucosal dissection.
Read More: What are the benefits of a balanced fund?
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.